抗病毒组合疗法用于持续性COVID-19在免疫功能低下的患者
Daniele Focosi1, Fabrizio Maggi2, Alessandra D'Abramo2
1North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
概括
组合抗病毒疗法对持续性COVID-19的免疫受损患者有希望. 这些治疗方法,包括小分子抗病毒药物和康复性血,为单一治疗提供了更安全,更有效的替代方案,降低了免疫逃逸和死亡的风险.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫功能低下的人因免疫反应受损而面临严重的COVID-19负担.
- 在这种人群中,标准抗病毒单一治疗通常对持续的SARS-CoV-2感染无效.
- 单疗可以导致与治疗相关的免疫逃脱,复发和增加死亡率.
研究的目的:
- 对免疫功能低下患者的COVID-19联合抗病毒疗法的疗效和安全性进行审查.
- 探索标准单一疗法之外的替代治疗策略.
主要方法:
- 进行了文学叙事审查.
- 在PubMed中搜索了COVID-19联合抗病毒疗法的病例报告,病例系列和临床试验.
主要成果:
- 小分子抗病毒药物的组合在小患者队列中是安全有效的.
- 将小分子抗病毒药物与被动免疫疗法结合起来也显示出希望.
- 报告的队列表明组合治疗的安全性和有效性概况有利.
结论:
- 联合抗病毒疗法是治疗免疫功能低下患者COVID-19的可行选择.
- 鉴于单克隆抗体的疗效下降,小分子抗病毒药物和康复性血的组合有希望.
- 这些组合策略可以减轻与单一治疗相关的风险,例如免疫逃脱和死亡率.
相关概念视频
Immunodeficiency Diseases
970
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
970
Retrovirus Life Cycles
46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Subviral Agents
33
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
33
Immune Response Against Viral Pathogens
811
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
811
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Pneumonia IV: Management
353
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
353


